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Abstract
Objective: Tissue hypoxia after blood loss, replantation
and flap reperfusion remains a challenging task in
surgery. Normovolemic hemodilution improves he-
morheologic properties without increasing oxygen car-
rying capacity. Red blood cell transfusion is the cur-
rent standard of treatment with its attendant risks.
The aim of this study was to investigate the potential
of the chemically modified hemoglobin, MP4, to re-
duce skin flap necrosis and its effect on selected blood
markers and kidneys.
Materials and Methods: Tissue ischemia was induced
in the ear of hairless mice (n=26). Hemodilution was
performed by replacing one third of blood volume
with the similar amount of MP4, dextran, or blood.
The extent of non-perfused tissue was assessed by in-
travital fluorescent microscopy.
Results: Of all groups, MP4 showed the smallest area
of no perfusion (in percentage of the ear ± SEM:
16.3% ± 2.4), the control group the largest (22.4% ±
3.5). Leukocytes showed a significant increase in the
MP4 and dextran group (from 8.7 to 13.6 respectively
15.4*109/l). On histology no changes of the kidneys
could be observed.
Conclusion: MP4 causes an increase of leukocytes, im-
proves the oxygen supply of the tissue and shows no
evidence of renal impairment.
Key words: MP4, hairless mice, intravital fluorescent
microscopy, oxygen carrier, free hemoglobin, intracar-
diac access, hemodilution
INTRODUCTION
The occurrence of tissue hypoxia after blood loss, re-
plantation, transplantation and flap reperfusion re-
mains a challenging task in surgery today. In particular,
the occurrence of tissue necrosis in skin flaps is a ma-
jor problem in microvascular surgery. Impaired micro-
circulation is known to be a frequent cause of is-
chemia/reperfusion injury [1-3]. The perfusion de-
pends on an equilibrium of blood pressure and heart
rate, vessel diameter and length, blood viscosity, and
interstitial fluid pressure, which is regulated by myo-
genic autoregulation, metabolic and neural control
mechanisms and many other factors [4]. Alteration of
one of these parameters can impair the perfusion of
the tissue. Vasoconstriction has been a major problem
in the clinical development of Hb-based O2 carriers. It
narrows the inner vessel diameter, weakening the al-
ready impaired microcirculation [5, 6]. With the conju-
gation of hemoglobin with polyethylene glycol the he-
moglobin lost its vasoconstrictive responses [7].
In the clinical setting, normovolemic hemodilution
is a well established method for improving the he-
morheologic properties of the supplying blood with-
out increasing the oxygen carrying capacity. The cur-
rent alternative consists of red blood cell transfusion
which still involves time consuming type and cross
matching, transmission of diseases, allergic reactions
and short shelf life. Besides the imbalance between re-
cipients and donors and the treatment of transfusion
associated complications, it creates an enormous in-
crease in costs that underlines the desirability of re-
placing red blood cell solutions with artificial oxygen
carriers. Intravenously administered artificial oxygen
carriers are intended to increase the reduced O2 carry-
ing capacity of blood in the case of acute severe ane-
mia, i.e. hemorrhagic shock or extreme normovolemic
hemodilution. Two groups of artificial O2 carriers are
currently being investigated: ultrapurified, stroma-free
hemoglobin solutions of human or bovine origin and
synthetically produced perfluorocarbon emulsions
(PFC). Chemically modified hemoglobin solutions
may be administered in large amounts and are suitable
for 1:1 replacement of blood losses in case of hemor-
rhage as well as for isovolemic exchange of blood [8].
The advantages of artificial oxygen carriers vs. red
blood cells are:
• reduced risk of transmitting infections because of
stroma-free hemoglobin solutions
• absence of immunologic risks
• long storage with no reduction in effectiveness
• increased availability (about four times the amount
of MP4 out of one unit of outdated human red
blood cells) [9].
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MP4 is human hemoglobin modified by surface conju-
gation of monofunctional maleimide-activated 5-kDa
polyethylene glycol to surface thiol groups [7]. The
modification has prolonged the plasma retention time
and has redressed the hypertensive and nephrotoxic
effect of former solutions [10]. MP4 has a low hemo-
globin concentration, a slightly lower viscosity and is
hyperoncotic to blood. Contrary to almost all other
hemoglobin solutions it possesses an increased oxygen
affinity [7]. The high oxygen affinity seems to be
counterproductive at first in the treatment of is-
chemia, but it can be assumed that, because of its high
oxygen affinity, MP4 reaches the capillary level with a
respectively higher load of oxygen. In accordance with
a higher blood-tissue gradient, the release of oxygen is
facilitated [11].
Experimental studies on animals during hemorrhag-
ic shock and extreme hemodilution have proven that
MP4 has a superior effect on the microcirculation,
compared to conventional therapies with crystalloidal
or colloidal solutions, by increasing tissue oxygenation
and functional capillary density [12, 13]. To the pre-
sent day no studies have investigated this effect under
local induced ischemia.
The aim of the present study is to investigate the
effects of MP4 on the microcirculation in ischemic tis-
sue and its potential to reduce skin flap necrosis com-
pared to dextran 70 and control groups, as well as its
effect on blood parameters and kidney morphology.
MATERIALS AND METHODS
ANIMALS
Hairless mice (SKH-1/hr, n = 26) aged between 6 and
7 weeks and weighing 24 - 27g were obtained (Charles
River, Sulzfeld, Germany) one week prior to the ex-
periments and were housed one per cage at 24ºC in a
12 hour dark/light cycle with standard laboratory food
and water ad libitum. The animals underwent general
anesthesia on each occasion during the actual flap cre-
ation as well as during the subsequent investigations.
All experiments have been carried out with ethical
committee approval and meet the standards required
by the UKCCCR guidelines. In addition, each proce-
dure was approved by the regional authorities accord-
ing to German animal care regulations, which comply
with the international guidelines of animal care and
use in scientific experiments (AZ 50.8735.1).
ANESTHESIA
All animals underwent general anesthesia performed by
spontaneous inhalation of Isoflurane-N2O( F iO2: 0.33,
FiN2O: 0.66, 0.015L/L Isoflurane, Forene®, Abbott
GmbH, Wiesbaden, Germany). To avoid hypothermia,
mice were placed onto a heated acryl glass observation
platform (Fig. 1). To create a single-pedicle arterial skin
flap model, the mouse ear was first extended onto the
platform by three microsurgical loops (10/0 Surgipro®,
Tyco®, Germany), which were pulled through the pe-
ripheral parts of the ear and fixed by three threads
(5/0 Surgipro®,T y c o ®, Germany). For improved trans-
lucency, isotonic saline (NaCl 0.9% B. Braun Ecobag®)
was applied between ear and platform to derive advan-
tage from adhesive forces.
APPLICATIONS
For contrast enhancement, the anesthetized animals
received an intravenous bolus injection over the tail
vein of 50µl FITC labeled dextran 150 kDa (Sigma
Chemicals Co., St. Louis, MO, USA) serving as a plas-
ma marker for intravital fluorescent microscopy (tube
29G, B.Braun, Melsungen, Germany); during the four
investigations the animals received altogether 200µl of
additional fluids intravenously due to the application
of the plasma marker. After flap creation, the demar-
cation line between perfused and non perfused tissue
could be directly visualized by intravital microscopy.
FLAP CREATION
We used the skin flap model of the ear of the hairless
mouse [14]. In the past the ear of hairless mice has
undergone different processes to investigate their in-
fluence on the microcirculation [14-18].
The neurovascular supply of the mouse ear is made
up of three bundles leading from the base of the ear to
the periphery. To create a single-pedicle skin flap mod-
el, the ear was first extended and fixed on the platform,
and then four fifths of its caudal base was incised,
leaving the flap thus created solely dependent on the
anterior neurovascular bundle for its nourishment.
INTRACARDIAC ACCESS
The intracardiac access for blood withdrawal as well as
for application of test solutions has proven in this
study to be less invasive, and also offers the advan-
tages of rapid preparation and low infection risk com-
pared to conventional central intravenous access.
Once the anesthetized animal has been placed on its
back, the withdrawal was carried out with a syringe
(needle diameter 29G) below the xiphoid at an angle
of about 15° towards the median line from right and
the same angle versus dorsal in a left-cranial direction
under constant aspiration control. The first withdrawal
of 500µl was replaced by the same amount of MP4,
dextran or blood. After flap creation 100µl were again
taken to determine the amount of free hemoglobin
and the hematocrit in order to check the success of
the application. The withdrawal was only performed
twice: once after application of MP4, dextran or blood
and once after completing the last recordings.
After each procedure the needle could be removed
without any subsequent bleeding and the animals
showed no reduced condition at any time. Altogether
one of 40 animals died during our study accidentally,
the heart showed no severe damage.
RECORDINGS
Before flap creation the unimpaired microcirculation
was assessed by intravital fluorescent microscopy (IFM)
(Axiotech vario, Carl Zeiss, Oberkochen, Germany). Anoverall view was achieved by a four fold objective re-
sulting in a total magnification of about 52 fold for
measurements of the non perfused area (NPA).
In order to be able to differentiate between in-
travascular occlusion and sufficient blood flow, red
blood cell flow was recorded by connecting the micro-
Fig. 1. Tissue ischemia was induced by severing four
fifths of the ear at its caudal base, leaving a single pedicle
for its nourishment. The snout is lying in an acryl glass
tube for general anesthesia performed by spontaneous
inhalation of Isoflurane-N2O.
Fig. 2. Non perfused area 24, 48 and 72h (left to right) after flap creation. The bright area shows perfusion due to the circulat-
ing fluorescent dye FITC, whereas the dark area is no longer perfused.
Fig. 3. shows a cross section of the ear of the hairless mouse. On the left in hematoxylin-eosin, on the right in TUNEL staining
72h post trauma.The picture on the left shows a cluster of proteins (eosinophilic (a)) in the area of necrosis/no perfusion (b)
followed by an area of granulocytes (purple (c)), marking off the vital (e) from the avital (b) tissue; (d) marks the border between
vital and avital tissue. TUNEL staining was used to find the exact border of necrotic/apoptotic and vital tissue. The vital cells
stain blue (f) and the necrotic/apoptotic cells red (g).scope with a video camera (AVT-BC 71, AVT-Horn,
Aalen, Germany) and a digital camera (Canon EOS
D60) and stored on a PC. Vessels with doubtful perfu-
sion on the photo could be checked up on the video
later. Because of the magnification no direct overview
could be achieved. Therefore 9 separately recorded
digital pictures of one ear were stored under a magni-
fication of 300dpi and later assembled into one pic-
ture with the help of the computer program Photo-
shop®. Microscopic observations were performed
before and after flap creation as well as after 24, 48
and 72h.
MEASUREMENTS
The measurement of ear size and area of non perfu-
sion was performed after assembling the different pic-
tures with the help of the computer program CapIm-
age® [19]. The borderline between perfused and non
perfused tissue was well demarked by the contrast en-
Fig. 4. The figure shows the non perfused area of the
ischaemic flap in percentage 24, 48 and 72 h after flap
creation with corresponding standard error of the
mean. Compared to both other groups MP4 presents
the smallest proportion of no perfusion over the
whole observation period, whereas the control group
demonstrated the most extended NPA at any given
observation. However no significance between all
groups could be seen.
Fig. 5. Amount of free hemo-
globin (MP4) five minutes post
intracardiac application of
MP4. The mean value was
0.67g/dl. Data are given for the
MP4 group only, no free hemo-
globin was found in the other
two groups.
Fig. 6. Percentage of hemat-
ocrit 72h post intracardiac in-
jection. The value of the MP4
and the dextran group was
about 38% 72h post injection.
*significantly different from
control group (p<0.05).hancement of FITC-dextran (Fig. 2). The measure-
ments were carried out 24, 48 and 72 h after flap cre-
ation. Measurements of nonperfused area are ex-
pressed as percentage of the created flap.
The blood analysis was performed using a blood
animal counter (scil Vet abc, scil animal care company,
Viernheim, Germany) before and after application of
the different solutions and on day 3. The free hemo-
globin was measured in the laboratory of the
Bergmannsheil Hospital, Ruhr-University Bochum
(Prof. M. Krieg).
The concentration of MP4 or free hemoglobin re-
spectively was determined by measuring the concen-
tration of free hemoglobin before and after injecting
the three solutions (blood, dextran and MP4). Since
the control group and the dextran group showed no
free hemoglobin, the concentration of free hemoglo-
bin in the MP4 group is assumed to be equal to that in
the mouse after injection. The extension of hemodilu-
tion was determined by the hematocrit (HCT) before
and after giving MP4, dextran and blood. The influ-
ence of each solution on blood parameters was then
investigated before and after flap creation and after 24,
48 and 72h.
STATISTICS
The commercially available computer program Sigma-
Stat‘ (Version 2.0, Jandel Scientific, Erkrath, Germany)
was used for statistical analysis of the data. Compar-
isons between different times were performed using




The smallest area of no perfusion as a percentage of
the size of the ear was seen in the MP4 group over the
observation period. However, no significance could be
demonstrated compared to the dextran and control
groups.
The proportion of the NPA in the MP4 group was
measured at 12.5% ± 1.9 after 24h, increasing to
16.8% ± 1.5 after 48h and finally dropping to 16.3% ±
2.4 after 72h. However, the proportion in both other
groups increased continuously. 24h after incision it
was measured in the dextran group at 13.2% ± 1.9, in-
creasing to 16.0% ± 1.5 (48h) and reaching 18.4% ±
1.2 after 72h. Over the whole observation period the
control group showed the largest NPA (24h: 16.7% ±
2.7; 48h: 20.8% ± 3.5; 72h: 22.4% ± 3.5) (Fig. 4).
The mean blood concentration of free hemoglobin
(MP4) in the MP4 group five minutes post intracardiac
injection was 0.67g/dl (Fig. 5). In all other groups the
free hemoglobin concentration was below the analyti-
cal detection limit.
We could not detect any morphological alterations
in the cross sections in HE staining of the kidneys in
the MP4 group compared with the control group.
The hematocrit in all animals that were given MP4
decreased visibly after injection of the test solution
and was measured on average at one third below start-
ing hematocrit (average hematocrit: 46.5% before,
30.9% after application of MP4) (Fig. 6). 72h after in-
duction of ischemia hematocrit had increased on aver-
a g eu pt o3 8 %( F i g .6 ) .
In the dextran group, hematocrit dropped a little
more than in MP4, on average 28.2% (average HCT:
46.3% before, 28.2% after application of dextran),
with an increase 72h later up to 38.1% on average (Fig.
6).
The white blood cells were raised significantly in
the dextran and MP4 groups 72h post intracardiac in-
jection from 8 to 13.6 respectively 15.4*109/l (Fig. 7).
Percutaneous intracardiac withdrawal of blood and
injection of fluids are safe and feasible without any se-
vere heart muscle damage. To evaluate the morpholog-
ical damage, histological sections in hematoxylin and
eosin staining of the myocardium were carried out: We
could detect some muscle damage, but without any
clinical importance. Altogether one of 40 animals died
accidentally during our study under anasthesia, the
heart showed no severe damage.
DISCUSSION
MP4 shows an obvious tendency to reduce the area of
no perfusion compared to the dextran and control
Fig. 7. White blood cells 72h post in-
tracardiac injection. A significant in-
crease could be found in the dextran
and MP4 groups compared to the
norm and control group. *significantly
different from control group (p<0.05).group, but this is not significant. A reason for the ab-
sence of significance could be the surgical alteration
of the anatomy due to incision of the ear. Compared
to published data of other groups, we measured quite
a small area of no perfusion. This could be explained
by the use of young mice, which show a higher func-
tional capillary density and a higher rate of anastomo-
s i st h a no l d e ro n e s[ 2 0 ,2 1 ] .
In addition, repetitive application and a higher con-
centration of MP4 could be necessary. An interesting
observation was the fact that the area of no perfusion
in the MP4 group showed no increase after 48 h,
whereas the areas in the other two groups extended
between 48 and 72 h. An explanation could be the im-
provement in oxygenation due to MP4. The tissue in
the area of no perfusion died in all three groups, but
the tissue that received a minimum of perfusion sur-
vived in the MP4 group due to adequate oxygenation,
whereas the oxygenation in the two other groups was
insufficient and resulted in additional NPA 72 hours
post induction of ischemia.
So far the influence of MP4 was investigated only
in systemic ischemia as an alternative substitute for
blood, which will probably be the main target in the
future [13, 22-24]. In our model we investigated a lo-
cally induced ischemia in addition to the hemodilution.
The values of less NPA and no further NPA after 48 h
could possibly be improved by higher MP4 concentra-
tions and repetitive applications; studies with a modi-
fied design are planned.
We could not find any morphologic changes in the
kidneys in the sense of necrotic tubuli or sedimenta-
tion of proteins, which are often caused by free hemo-
globin [25]. This probably shows the positive effect of
the chemical modification of free hemoglobin with
polyethylene glycol, which enables the normovolemic
hemodilution of about 1/3 of the blood volume in
our model without causing any severe damage.
The significant increase in leukocytes in the MP4
and dextran group after 72h could not be explained.
The animals showed no alterations in behavior and
had the same weight compared to the control group.
The free hemoglobin could cause reactions of the im-
mune system, but we would wonder about the low
variance. Leukocytosis due to dextran is described in
rats (colitis after drinking dextran sulphate sodium), in
mice and rats after giving dextran sulphate [26-28]. In
rhesus monkeys only a transient elevation of aspartate
aminotransferase, alanine aminotransferase and lactate
dehydrogenase (LDH) was found 3 days after applica-
tion of MP4, no elevation of leukocytes was detected
[23]. In humans a slight elevation of amylase and li-
pase could be detected [29, 30].
The intracardiac access reduced the mortality com-
pared to central intravenous catheters in our laborato-
ry and was easy to handle. One advantage of our mod-
el was the lack of hairs, which allowed a direct view of
the xyphoid and facilitated orientation.
In summary, the oxygen carrier MP4 shows a clear
tendency to reduce the extent of NPA and therefore
necrosis compared to the dextran and control groups,
and, in contrast to the other groups, the area of no
perfusion in the MP4 group showed no increase after
48 h.
Further studies with different MP4 concentrations
and repetitive applications should be conducted to
find out whether giving MP4 instead of other com-
monly used substitutes definitely represents an advan-
tage for flap survival.
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